Summary by Futu AI
Novo Nordisk A/S, a leading global healthcare company, has announced the progress of its share repurchase program on September 9, 2024. The program, which began on August 7, 2024, is part of a larger 12-month share repurchase plan initiated on February 6, 2024, with a total budget of up to DKK 20 billion. As of September 6, 2024, Novo Nordisk has repurchased 12,023,313 B shares at an average price of DKK 880.98 per share, amounting to DKK 10,592,256,521. The current phase of the program aims to repurchase B shares for up to DKK 2.4 billion between August 7 and November 4, 2024. Since the last announcement, 956,187 B shares have been acquired for a total of DKK 864,550,471. Novo Nordisk now holds 13,351,944 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.